-
Local context and the targeted populations' particular issues are important when research institutions strive to improve their human research subjects protection. IRBs and their mandate to include community members help meet this challenge.
-
The proposed Common Rule changes that would permit a central IRB to review multiple site studies drew passionate responses both for and against the change in the early comments submitted to the U.S. Department of Health and Human Services (HHS).
-
For years, federal regulations have deemed the research use of deidentified blood and tissue samples collected in clinical procedures to be non-human subjects research, and therefore has not required informed consent from the patients from whom they were taken.
-
IRBs wrestling with mounting numbers of adverse event (AE) reports have been encouraged to get a handle on which items need to be reported and which don't. But often, that choice isn't only up to the IRBs study coordinators will submit items even when they're told they don't have to.
-
When Vanderbilt University's BioVU biobank considered whether to add pediatric biospecimens to the adult samples already being gathered, officials faced a range of ethical questions.
-
-
Not every patient experiencing shortness of breath needs to have definitive airway intervention such as intubation, says Sybil Murray, RN, an ED nurse at St. Anthony's Medical Center in St. Louis, MO.
-
Your next stroke patient may be aware there is a drug called tissue plasminogen activator (tPA), but he or she probably won't realize how few stroke patients are actually candidates for this treatment.
-
If your patient has aspirated prior to being intubated, he or she is at increased risk for ventilator-associated pneumonia (VAP), warns Nicole Schiever, RN, MSN, ED team leader at Riverside Medical Center in Kankakee, IL.
-
When an ED physician at Scripps Mercy San Diego (CA) decided to order lorazepam to help an elderly man sleep, the ED nurse caring for the patient got a very unexpected reaction.